Skip to main content

Advertisement

Table 3 Procedure related complications

From: Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?

Complications All patients (n = 135) Tranexamic acid (n = 52) Control (n = 83) P-value
Major bleeding complications, n (%) 20 (14.8) 3 (5.8) 17 (20.5) 0.024
Reoperationa, n (%) 8 (5.9) 0 (0.0) 8 (9.6) 0.023
RBC transfusiona, n (%) 15 (11.1) 2 (3.8) 13 (15.7) 0.047
Hemothoraxa, n (%) 1 (0.7) 0 (0.0) 1 (1.2) 1.0
Pericardial effusiona, n (%) 3 (2.2) 1 (1.9) 2 (2.4) 1.0
Life-threatening bleeda, n (%) 1 (0.7) 0 (0.0) 1 (1.2) 1.0
Pocket hematoma, n (%) 26 (19.3) 4 (7.7) 22 (26.5) 0.013
Pocket related infection, n (%) 1 (0.7) 0 (0.0) 1 (1.2) 1.0
Pneumothorax, n (%) 2 (1.4) 1 (1.9) 1 (1.2) 1.0
  1. RBC red blood cells. aCounted events were presented (If a patient experienced multiple major bleeding complications, the clinical time course was reviewed to ensure that complications counted were distinctly separate events related to the procedure)